Fasting-Mimetic Supplements: Berberine & Rapamycin

What Is a Caloric Restriction Mimetic?

Caloric restriction (CR) — reducing caloric intake by 20–40% while maintaining adequate nutrition — is the most consistently demonstrated intervention for extending healthy lifespan across species, from yeast to rodents to primates. A 2012 study (Colman et al., Nature Communications) following rhesus monkeys for 23 years found caloric restriction reduced age-related disease incidence and increased survival.

A caloric restriction mimetic is a compound that may activate some of the same cellular pathways as caloric restriction without requiring actual food restriction. The primary pathways of interest:

• mTOR inhibition: mTOR (mechanistic target of rapamycin) is a nutrient-sensing kinase that promotes anabolism when nutrients are abundant. CR inhibits mTOR; mTOR inhibition has extended lifespan in multiple species.
• AMPK activation: AMPK is activated when cellular energy is low (during fasting or exercise). CR activates AMPK; AMPK activation has anti-aging effects in multiple models.
• Sirtuin activation: Sirtuins are NAD+-dependent deacetylases activated by CR; SIRT1 activation promotes stress resistance and metabolic efficiency.
• Autophagy induction: CR induces autophagy via mTOR inhibition and AMPK activation.

Rapamycin: The Most Studied mTOR Inhibitor

Rapamycin (sirolimus) is a prescription immunosuppressant drug — an antibiotic originally isolated from soil bacteria on Easter Island (Rapa Nui, hence the name). It inhibits mTOR directly and is used clinically to prevent organ rejection after transplantation.

Longevity Research

Rapamycin has the strongest current evidence for lifespan extension in mammals of any pharmacological compound:

• A landmark 2009 study (Harrison et al., Nature) found rapamycin extended lifespan in mice by 9–14%, even when initiated at age 20 months (roughly equivalent to 60 years in humans). This was one of the first demonstrations that lifespan extension was possible with a drug intervention starting in middle age.
• Multiple subsequent studies have replicated and extended this finding.
• Rapamycin also appears to extend healthspan (time in good health) in mice, reducing cancer incidence and improving age-related functional decline.

Human Status

Rapamycin is not approved for longevity use in humans and is a prescription immunosuppressant. A series of trials are now exploring low-dose intermittent rapamycin ("rapalogs") in healthy aging adults (including the PEARL and TRIAD trials), with preliminary results suggesting improved immune function markers without the immunosuppressive side effects seen at transplant doses.

Berberine: The Accessible AMPK Activator

Berberine is an alkaloid compound found in several plants including Berberis vulgaris (barberry), Coptis chinensis (goldenseal), and others. It activates AMPK — the same cellular energy sensor activated by fasting and exercise.

Metabolic Research

Berberine has extensive human clinical trial data, primarily in metabolic conditions:

• A 2008 RCT (Metabolism, Zhang et al., n=116) found berberine (500mg three times daily for 3 months) was as effective as metformin for reducing HbA1c, fasting glucose, and postprandial glucose in type 2 diabetes patients — a striking finding.
• A 2012 meta-analysis of berberine RCTs in T2DM (Dong et al., Evidence-Based Complementary and Alternative Medicine) found significant improvements in glycemic and lipid parameters.
• Berberine also has evidence for reducing LDL cholesterol (roughly 20–30% in multiple trials), potentially via PCSK9 inhibition and LDLR upregulation.

Longevity/Autophagy Mechanisms

Beyond metabolic effects, berberine:

• Activates AMPK → mTOR inhibition → autophagy induction
• Has anti-inflammatory effects via NF-κB inhibition
• Has extended lifespan in multiple animal models including C. elegans and flies

The Metformin Comparison

Berberine's mechanism overlaps substantially with metformin, the most-used diabetes drug that is also being studied as a longevity agent (the TAME trial). Both activate AMPK (though via different mechanisms), both improve insulin sensitivity, both may inhibit mitochondrial complex I.

Whether berberine's longevity benefits will match metformin's (when studied) is unknown.

Other Caloric Restriction Mimetics

Metformin (Research Context)

Though a prescription drug, metformin deserves mention. The TAME (Targeting Aging with Metformin) trial — a large, NIH-funded RCT in 3,000 adults — is testing whether metformin prevents age-related diseases. Results are expected in the late 2020s.

EGCG (Green Tea Extract)

Epigallocatechin gallate (EGCG) is the primary catechin in green tea. It has AMPK-activating and autophagy-inducing properties in cell and animal studies. Human evidence for longevity effects is limited to observational studies showing green tea consumption associated with reduced all-cause mortality in Japanese populations.

Quercetin

Quercetin activates SIRT1 and AMPK in cell studies and has senolytic (senescent cell clearing) properties that overlap with caloric restriction mechanisms. It is one of the more interesting multi-mechanism longevity compounds.

Nicotinamide Riboside (NR) and NMN

Both raise NAD+ levels, supporting sirtuin activity — a CR-mimetic pathway. See the dedicated NMN article for more detail.

Comparing the Options

Related: Zone 2 Cardio: Low-Intensity Training for Longevity · Why Men Die Earlier: 5 Fixable Risk Factors · Intermittent Fasting Calculator